Statin Contrast Induced Nephropathy Prevention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 500 participants.

Also called NCT01185938

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 500 participants (enrolled count) (from the registry)
Sponsor
Centro Cardiopatici Toscani (from the registry)
Registry
  • NCT NCT01185938
Other papers using this trial's data
  • Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study American heart journal, 2014-11 DOI, PubMed 25440809
  • Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome) Journal of the American College of Cardiology, 2014 DOI, PubMed 24076283
  • Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention) JACC. Cardiovascular interventions, 2014-12 DOI, PubMed 25523533

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01185938. Randomized; no masking; primary purpose prevention. Start 2010-07 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Statin Contrast Induced Nephropathy Prevention
Acronym
PRATO-ACS
Condition
Acute Coronary Syndrome
Intervention (Drug)
Rosuvastatin
Lead sponsor
Centro Cardiopatici Toscani (class: other)

Record details

Record id
cardio:ct-nct01185938
Content hash
c6556aebebf9c20cba3deda23427be62ca60f9ab118bb10624d6d392d1e6bae1